As life science businesses focus on managing the impact of COVID-19 and working on solutions to fight this pandemic, regulatory responsibilities remain a pressing concern that must not fall in priority. In the immediate future, planning for compliance deadlines is a matter of urgency, whether to keep products on the market or meet emerging demands rapidly. Steve Cottrell, President, Maetrics focuses on the outsourcing solutions that will make more efficient use of limited internal resources.

[wonderplugin_pdf src=”https://www.biopharmaceuticalmedia.com/wp-content/uploads/2020/12/Compliance-Capacity_a-checklist-to.pdf” width=”100%” height=”900px” style=”border:0;”]